Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
BioHarvest Sciences ( (TSE:BHSC) ) has provided an update.
On January 22, 2025, BioHarvest Sciences Inc. announced the appointment of Sharon Malka to its board of directors, effective immediately. This strategic addition brings over 25 years of financial and capital markets experience to the company, aligning with its growth phase. Malka’s expertise is expected to strengthen BioHarvest’s position as it scales its Botanical Synthesis technology and expands operations, offering potential benefits to stakeholders and enhancing the company’s competitive edge.
More about BioHarvest Sciences
BioHarvest Sciences Inc. is a leader in the Botanical Synthesis industry, known for its patented technology platform that allows the growth of plant-based molecules without cultivating the entire plant. The company operates within two main business verticals: providing contract development and production services for complex molecules and creating proprietary nutraceutical health and wellness products, including dietary supplements.
YTD Price Performance: -5.91%
Average Trading Volume: 5,006
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$143.5M
Learn more about BHSC stock on TipRanks’ Stock Analysis page.
